References
- Deng, G., Zhou, G., Zhang, R., Zhai, Y., Zhao, W., Yan, Z., Deng, C., Yuan, X., Xu, B., Dong, X., et al. (2008). Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 134, 716-726. https://doi.org/10.1053/j.gastro.2007.12.044
-
Gong, L.-L., Zhao, B.-B., Fan, W.-F., Gong, L.-Y., Chen, C.-F., Liu, J.-J., and Lu, X. (2015). Correlations of IFN-
${\gamma}$ -inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians. Int. J. Clin. Exp. Pathol. 8, 8367-8375. - Jaroszewicz, J., Ho, H., Markova, A., Deterding, K., Wursthorn, K., Schulz, S., Bock, C.T., Tillmann, H.L., Manns, M.P., Wedemeyer, H., et al. (2011). Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues. Antiviral Ther. 16, 915-924. https://doi.org/10.3851/IMP1866
- Sahin, H., Borkham-Kamphorst, E., do O, N.T., Berres, M.L., Kaldenbach, M., Schmitz, P., Weiskirchen, R., Liedtke, C., Streetz, K.L., Maedler, K., et al. (2013). Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes. Hepatology 57, 797-805. https://doi.org/10.1002/hep.26069
- Scheuer, P.J. (1991). Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13, 372-374. https://doi.org/10.1016/0168-8278(91)90084-O
- Sevgi, D.Y., Bayraktar, B., Gunduz, A., Ozguven, B.Y., Togay, A., Bulut, E., Uzun, N., and Dokmetas, I. (2016). Serum soluble urokinase-type plasminogen activator receptor and interferongamma-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B. Wien. Klin. Wochenschr. 128, 28-33. https://doi.org/10.1007/s00508-015-0886-4
- Sonneveld, M.J., Arends, P., Boonstra, A., Hansen, B.E., and Janssen, H.L. (2013). Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B. J. Hepatol. 58, 898-903. https://doi.org/10.1016/j.jhep.2013.01.029
- Wang, Y., Zhao, C., Zhang, L., Yu, W., Shen, C., Wang, W., Zhen, Z., and Zhou, J. (2014). Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients. Antiviral Res. 103, 51-59. https://doi.org/10.1016/j.antiviral.2014.01.001
- Willemse, S.B., Jansen, L., de Niet, A., Sinnige, M.J., Takkenberg, R.B., Verheij, J., Kootstra, N.A., and Reesink, H.W. (2016). Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAgpositive chronic hepatitis B patients treated with peginterferon and adefovir. Antiviral Res. 131, 148-155. https://doi.org/10.1016/j.antiviral.2016.05.002
- Wong, G.L., Chan, H.L., Chan, H.Y., Tse, C.H., Chim, A.M., Lo, A.O., and Wong, V.W. (2016). Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B. Aliment Pharmacol Ther. 43, 145-153. https://doi.org/10.1111/apt.13447
- Xu, R., Lin, F., He, J., Jin, L., Zhang, J.Y., Fu, J., Liu, H., Wang, S., Zhang, Z., and Wang, F.S. (2013). Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B. Immunology 138, 228-234. https://doi.org/10.1111/imm.12024
- Yoshio, S., Sugiyama, M., Shoji, H., Mano, Y., Mita, E., Okamoto, T., Matsuura, Y., Okuno, A., Takikawa, O., Mizokami, M., et al. (2016). Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. Hepatology 63, 83-94. https://doi.org/10.1002/hep.28282
- Zhang, J.Y., Zhang, Z., Lin, F., Zou, Z.S., Xu, R.N., Jin, L., Fu, J.L., Shi, F., Shi, M., Wang, H.F., et al. (2010). Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51, 81-91. https://doi.org/10.1002/hep.23273
- Zhang, G., Chen, Y., BilalWaqar, A., Han, L., Jia, M., Xu, C., and Yu, Q. (2015). Quantitative analysis of rabbit coronary atherosclerosis. Practical techniques utilizing open-source software. Anal. Quant. Cytol. Histol. 37, 115-122.
Cited by
- Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy vol.220, pp.6, 2019, https://doi.org/10.1093/infdis/jiz252
- Soluble immune markers in the different phases of chronic hepatitis B virus infection vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-019-50729-5
- Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability vol.10, pp.16, 2020, https://doi.org/10.7150/thno.44960
- Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B vol.14, pp.4, 2017, https://doi.org/10.1080/17474124.2020.1738219
- Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV vol.9, pp.3, 2017, https://doi.org/10.1128/spectrum.01810-21